Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylonitrile SCHEMBL7774781 | 0.96 | ALDH1A1 (0.82) | ALDH1A1TSHR | |
| Acrylonitrile SCHEMBL22216 | 0.96 | — | — | |
| Acrylonitrile SCHEMBL7856348 | 0.96 | ALDH1A1 (0.82) | ALDH1A1TSHR | |
| Acrylonitrile SCHEMBL175546 | 0.96 | — | — | |
| Acrylonitrile SCHEMBL7182391 | 0.96 | ALDH1A1 (0.82) | ALDH1A1TSHR | |
| Acrylonitrile SCHEMBL25232752 | 0.96 | ALDH1A1 (0.82) | ALDH1A1TSHR | |
| Acrylonitrile SCHEMBL11137227 | 0.92 | — | — | |
| Acrylonitrile SCHEMBL15650040 | 0.92 | — | — | |
| Acrylonitrile SCHEMBL4130569 | 0.92 | — | — | |
| Acrylonitrile SCHEMBL8519661 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105001521-B | Ionomer modified polypropylene composite material generated by in-situ reaction and preparing method thereof | 南京鸿瑞塑料制品有限公司 | 2017-05-24 | — | — | CN | claimed |
| CN-105001521-A | Ionomer modified polypropylene composite material generated by in-situ reaction and preparing method thereof | NANJING HONGRUI PLASTIC PRODUCTS CO LTD | 2015-10-28 | — | — | CN | claimed |
| US-7794751-B2 | Medicament incorporation matrix | SURMODICS, INC. (US) | 2010-09-14 | — | — | US | claimed |
| US-20060165751-A1 | Medicament incorporation matrix | Surmodics Coatings, LLC | 2006-07-27 | — | — | US | claimed |
| EP-1309360-B1 | MEDICAMENT INCORPORATION MATRIX | SURMODICS INC (US) | 2006-04-19 | — | — | EP | claimed |
| JP-2004520088-A | — | — | 2004-07-08 | — | — | JP | claimed |
| EP-1309360-A2 | MEDICAMENT INCORPORATION MATRIX | SurModics, Inc. (US) | 2003-05-14 | — | — | EP | claimed |
| US-20020041899-A1 | Medicament incorporation matrix | Surmodics Coatings, LLC | 2002-04-11 | — | — | US | claimed |
| WO-2002013871-A2 | MEDICAMENT INCORPORATION MATRIX | SURMODICS, INC. (US) | 2002-02-21 | — | — | WO | claimed |
| EP-3843801-B1 | DEVICE FOR BONE MATERIAL HYDRATION | WARSAW ORTHOPEDIC INC (US) | 2024-07-17 | — | — | EP | disclosed |
| US-12004791-B2 | Bone material hydration devices and methods | WARSAW ORTHOPEDIC, INC. (US) | 2024-06-11 | — | — | US | disclosed |
| US-20230157740-A1 | BONE MATERIAL HYDRATION DEVICES AND METHODS | WARSAW ORTHOPEDIC INC. (US) | 2023-05-25 | — | — | US | disclosed |
| US-11564723-B2 | Bone material hydration devices and methods | WARSAW ORTHOPEDIC, INC. (US) | 2023-01-31 | — | — | US | disclosed |
| CN-113015546-B | Bone material hydration apparatus and method | 华沙整形外科股份有限公司 | 2022-10-21 | — | — | CN | disclosed |
| WO-2000000239-A1 | MODULAR CYTOMIMETIC BIOMATERIALS, TRANSPORT STUDIES, PREPARATION AND UTILIZATION THEREOF | EMORY UNIVERSITY (US) | 2000-01-06 | — | — | WO | disclosed |
| EP-0941740-A2 | Attachment of biomolecules to surfaces of medical devices | MEDTRONIC, INC. (US) | 1999-09-15 | — | — | EP | disclosed |
| CN-1176990-A | Method for producing olefines by steam cracking heavy gas oil or raffinate oil from solvent extraction | RES INST OF YANSHAN PETRO CHEM (CN) | 1998-03-25 | — | — | CN | disclosed |
| US-5711959-A | WITH PHOSPHOLIPID COVALENTLY ATTACHED | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1998-01-27 | — | — | US | disclosed |
| WO-1996029102-A1 | BIOCOMPATIBLE MATERIALS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1996-09-26 | — | — | WO | disclosed |
| CN-86106964-A | ONE PACKAGE STRUCTUAL ADHESIVE COMPOSITIONS | — | 1987-06-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020041899-A1 | Medicament incorporation matrix | COL14A1, MATR3, ECPAS | ALDH1A1 1028/4885TSHR 4616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.